Clinical Trials Logo

Autophagy clinical trials

View clinical trials related to Autophagy.

Filter by:

NCT ID: NCT06115551 Active, not recruiting - Diet Clinical Trials

Fasting Mimicking Diet and Autophagy

Start date: May 2, 2023
Phase: N/A
Study type: Interventional

This study aims to evaluates autophagy in circulating white blood cells from generally healthy human volunteers exposed to fasting mimicking diet (FMD), a 5-day dietary regimen.

NCT ID: NCT05817448 Not yet recruiting - Hypoxia Clinical Trials

Hypoxia-induced Autophagy in the Pathogenesis of MAP

Start date: September 2023
Phase:
Study type: Observational

To investigate the role of HIF 1α and LC3B in the pathogenesis of MAP, to evaluate the role of MMP-9 in the antenatal prediction of MAP, and to compare the expression of HIF1α, LC3B, and level MMP-9 between patients of placenta previa with MAP and patients with normal placentation.

NCT ID: NCT05524376 Not yet recruiting - Sepsis Clinical Trials

Regulatory Network and Diagnostic Value of Key Autophagy-related Genes in Sepsis

Start date: September 1, 2022
Phase:
Study type: Observational

Autophagy plays an important role in the occurrence and development of sepsis. This study aims to explore and verify the key autophagy-related genes in sepsis, then construct their regulatory networks and evaluate their potential diagnostic value, so as to provide new ideas for the diagnosis and treatment of sepsis.

NCT ID: NCT05279638 Recruiting - Psoriasis Vulgaris Clinical Trials

ATG5 as a Serum Marker of Autophagy in Psoriatic Patient

Start date: February 1, 2022
Phase:
Study type: Observational

it will be of interest to know the ATG 5 as a serum marker of autophagy in serum of psoriasis vulgairs patients and explore its relationship with psoriasis severity.

NCT ID: NCT04842864 Withdrawn - Fasting Clinical Trials

Time Course for Fasting-induced Autophagy in Humans

Start date: November 19, 2021
Phase: N/A
Study type: Interventional

Autophagy, which involves the degradation of aged or damaged cellular components, has been shown to extend healthspan and lifespan in multiple organisms, including flies, worms, and mice. Research has also demonstrated that autophagy declines with age in these simpler experimental models. However, human studies are lacking. Our study seeks to determine whether fasting, a robust stimulus of autophagy, upregulates autophagy in humans, and whether autophagy is reduced in healthy older people compared to healthy younger individuals.

NCT ID: NCT04706000 Completed - Endometrial Polyp Clinical Trials

Autophagy Markers in Endometrial Polyps

Start date: January 8, 2021
Phase:
Study type: Observational

The aim of this research is to evaluate autophagy markers in patients with endometrial polyps

NCT ID: NCT04160455 Recruiting - HIV Infections Clinical Trials

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

ATGALIG-HIV
Start date: November 7, 2019
Phase:
Study type: Observational

Little is known about autophagy during HIV infection. Recently, two different teams reported important dysfunctions of autophagy in HIV-infected patients despite sustained suppressive antiretroviral therapy. As altered autophagy is strongly linked to cellular senescence and chronic inflammation, two hallmarks of HIV-infected patients despite long-term suppressive antiretroviral therapy, it is important to improve our knowledge in the area. Our main objective is to determine whether all or part of mononuclear cell subpopulations (CD4+ and CD8+ T lymphocytes, and monocytes) exhibit a defect in autophagy function in a cohort of HIV-infected patients who are virologically-controlled (plasma HIV RNA <50 copies / ml) either spontaneously (i.e. HIV controllers or post-treatment controllers) or after they started antiretroviral therapy at different time points (i.e. at the acute or chronic phases), as compared with a control group (i.e. uninfected healthy blood donors).

NCT ID: NCT03925753 Completed - Autophagy Clinical Trials

Correlation Between Autophagy-related Proteins and Inflammatory Markers in Hemodialysis Patients

Start date: March 1, 2019
Phase:
Study type: Observational

One recent study demonstrated impaired autophagy in patients receiving hemodialysis (HD). To clarify whether this alteration is related to the inflammatory state in HD patients, we focused on basal autophagy in peripheral blood mononuclear cells (PBMCs) of HD patients with and without inflammation and controls. PBMCs were harvested using Ficoll density gradient centrifugation . Levels of the autophagy-associated proteins ubiquitin-binding protein p62 (p62), microtubule-associated proteins 1A/1B light chain 3A (LC3I/II) and beclin-1 in PBMCs will be detected by western blotting. Enzyme-linked immunosorbent assay kits will be used to detect the serum concentrations of interleukin (IL)-6, liposaccharide-binding protein (LBP) and tumor necrosis factor (TNF)-α.

NCT ID: NCT03371758 Recruiting - Autophagy Clinical Trials

Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo

Start date: January 2017
Phase: N/A
Study type: Interventional

The exact mechanism of impairment of autophagy in vitiligo has not yet been determined.

NCT ID: NCT03267160 Completed - Clinical trials for Hemodynamic Instability

A Study of Exosome Proteomics and Hemodynamics in Sepsis

Start date: January 18, 2017
Phase:
Study type: Observational

This research will be the first study for exosomes purified in blood and urine from septic patients who had multiple organ failures. Proteomics studies in exosomes from blood or urine specimens. Analyze autophage, and apoptosis related biomarkers of exosomes by bioinformatics. To find the correlations between exosomes biomarkers and hemodynamic parameters.